SG11201805264RA - Infant formula comprising human milk peptides - Google Patents

Infant formula comprising human milk peptides

Info

Publication number
SG11201805264RA
SG11201805264RA SG11201805264RA SG11201805264RA SG11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA
Authority
SG
Singapore
Prior art keywords
international
infant formula
peptides
auckland
december
Prior art date
Application number
SG11201805264RA
Other languages
English (en)
Inventor
Andrew John Clarke
Malav Suchin Trivedi
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of SG11201805264RA publication Critical patent/SG11201805264RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/16Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202Casein or caseinates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • A23V2250/542Animal Protein
    • A23V2250/5424Dairy protein
    • A23V2250/54246Casein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pediatric Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11201805264RA 2015-12-22 2016-12-21 Infant formula comprising human milk peptides SG11201805264RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562270955P 2015-12-22 2015-12-22
PCT/NZ2016/050203 WO2017111618A1 (en) 2015-12-22 2016-12-21 Infant formula comprising human milk peptides

Publications (1)

Publication Number Publication Date
SG11201805264RA true SG11201805264RA (en) 2018-07-30

Family

ID=59090893

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805264RA SG11201805264RA (en) 2015-12-22 2016-12-21 Infant formula comprising human milk peptides

Country Status (16)

Country Link
US (1) US20190000128A1 (ru)
EP (1) EP3393493A4 (ru)
JP (1) JP2018537997A (ru)
KR (1) KR20180096704A (ru)
CN (1) CN108472335A (ru)
AU (1) AU2016377254A1 (ru)
BR (1) BR112018012922A2 (ru)
CA (1) CA3009360A1 (ru)
CL (1) CL2018001728A1 (ru)
IL (1) IL260201A (ru)
MX (1) MX2018007819A (ru)
PH (1) PH12018550097A1 (ru)
RU (1) RU2018123201A (ru)
SG (1) SG11201805264RA (ru)
TW (1) TW201722295A (ru)
WO (1) WO2017111618A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ746167A (en) * 2016-03-30 2023-04-28 A2 Milk Co Ltd Beta-caseins and cognitive function
BR102019023798A2 (pt) * 2019-11-12 2021-05-25 José Ferreira Nunes composto lácteo de água de coco e leite de cabra e uso do composto
AU2021301233A1 (en) * 2020-07-01 2023-01-05 Frieslandcampina Nederland B.V. Process for the preparation of a powdery composition comprising bioactive molecules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
WO1993004171A1 (en) * 1991-08-19 1993-03-04 Symbicom Aktiebolag Human beta-casein, process for producing it and use thereof
JP2003503038A (ja) * 1999-06-29 2003-01-28 ザ・ニュージーランド・ミルク・インスティチュート・リミテッド 乳を主成分とする予防的補助食品
CN103315063A (zh) * 2012-03-19 2013-09-25 基斯有限公司 可预防疾病的婴儿配方奶粉
SG10201801156RA (en) * 2013-08-23 2018-03-28 A2 Milk Co Ltd Beta-casein a2 and blood glucose levels

Also Published As

Publication number Publication date
KR20180096704A (ko) 2018-08-29
TW201722295A (zh) 2017-07-01
JP2018537997A (ja) 2018-12-27
EP3393493A4 (en) 2019-06-26
PH12018550097A1 (en) 2019-02-11
CL2018001728A1 (es) 2018-09-28
CN108472335A (zh) 2018-08-31
US20190000128A1 (en) 2019-01-03
MX2018007819A (es) 2018-12-17
BR112018012922A2 (pt) 2018-12-11
IL260201A (en) 2018-07-31
EP3393493A1 (en) 2018-10-31
WO2017111618A1 (en) 2017-06-29
AU2016377254A1 (en) 2018-07-12
RU2018123201A3 (ru) 2020-03-02
RU2018123201A (ru) 2020-01-23
CA3009360A1 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
SG11201901700UA (en) Biaryl compounds useful as immunomodulators
SG11201900269XA (en) Channel sensing for independent links
SG11201903882VA (en) Il-2 variants for the treatment of autoimmune diseases
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201807912SA (en) Vaccine against rsv
SG11201805072PA (en) Nicotine powder delivery system
SG11201805709RA (en) Anti-pro/latent myostatin antibodies and methods of use thereof
SG11201809374VA (en) Cd40l-fc fusion polypeptides and methods of use thereof
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201901995TA (en) Crystalline and salt forms of ppar agonist compounds
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201807593TA (en) Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
SG11201810429UA (en) Anti-cd19 antibody formulations
SG11201909807TA (en) Methods of manufacturing of niraparib
SG11201805204WA (en) Nicotine particle capsule
SG11201810965YA (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
SG11201903193WA (en) Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate
SG11201804821PA (en) A beverage capsule
SG11201906778RA (en) Improved methods for assessing risk of developing breast cancer
SG11201908091QA (en) Aqueous anti-pd-l1 antibody formulation
SG11201810934TA (en) Microparticles comprising a sulphur-containing compound
SG11201907896PA (en) Optical system for monitoring the movement of people through a passageway